New report highlights public health risks and increasing availability of ‘designer benzodiazepines’ in Europe

, rubrika EMCDDA news

New benzodiazepines, which are not controlled by international drug laws, come under the spotlight today in a new report released by the EU drugs agency (EMCDDA) (1). Often marketed as ‘designer benzodiazepines’, these substances are sold as ‘legal’ replacements for controlled benzodiazepines and are becoming increasingly available in Europe. 09.06.2021  New benzodiazepines under the spotlight

TOPlist